Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update

Infection Control and Hospital Epidemiology

Volumn 35, Issue 7, 2014, Pages 753-771

  Marschall, Jonas ^a,b   Mermel, Leonard A ^c   Fakih, Mohamad ^d   Hadaway, Lynn ^e   Kallen, Alexander ^f   O'Grady, Naomi P ^g   Pettis, Ann Marie ^h   Rupp, Mark E ⁱ   Sandora, Thomas ^j   Maragakis, Lisa L ^k   Yokoe, Deborah S ^l  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c BROWN UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Lynn Hadaway Associates Inc   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATHETER CARE; CATHETER INFECTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; CONTROL STRATEGY; DISEASE SURVEILLANCE; HEALTHCARE ASSOCIATED INFECTION; HEMODIALYSIS PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MEDICAL AUDIT; MICROBIAL COLONIZATION; OUTCOME ASSESSMENT; PULMONARY ARTERY CATHETER; RISK FACTOR; BACTEREMIA; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; BLOODSTREAM INFECTION; CHECKLIST; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HEMODIALYSIS; HOSPITAL; HOSPITALIZATION; META ANALYSIS (TOPIC); NEUTROPENIA; REDUNDANCY ANALYSIS; RISK ASSESSMENT; TRAINING; ULTRASOUND;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS;

CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; POLYSPORIN; PSEUDOMONIC ACID;

EID: 84902969294     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/676533     Document Type: Article

References (258)

1. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S22-S30
2. Yokoe DS, Anderson DJ, Berenholtz SM, et al. Introduction to "A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates." Infect Control Hosp Epidemiol 2014;35(5):455-459
3. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81(9):1159-1171
4. Esteve F, Pujol M, Limon E, et al. Bloodstream infection related to catheter connections: a prospective trial of two connection systems. J Hosp Infect 2007;67(1):30-34
5. Climo M, Diekema D, Warren DK, et al. Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the Prevention Epicenter Program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 2003;24(12): 942-945
6. Vonberg RP, Behnke M, Geffers C, et al. Device-associated infection rates for non-intensive care unit patients. Infect Control Hosp Epidemiol 2006;27(4):357-361
7. Marschall J, Leone C, Jones M, Nihill D, Fraser VJ, Warren DK. Catheter-associated bloodstream infections in general medical patients outside the intensive care unit: a surveillance study. Infect Control Hosp Epidemiol 2007;28(8):905-909
8. Vital signs: central line-associated blood stream infections- United States, 2001, 2008, and 2 MMWR Morb Mortal Wkly Rep 2011;60(8):243-248
9. Kallen AJ, Patel PR, O'Grady NP. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis 2010;51(3): 335-341
10. Zingg W, Sandoz L, Inan C, et al. Hospital-wide survey of the use of central venous catheters. J Hosp Infect 2011;77(4):304-308
11. Xue H, Ix JH, Wang W, et al. Hemodialysis access usage patterns in the incident dialysis year and associated catheterrelated complications. Am J Kidney Dis 2013;61(1):123-130
12. Loftus RW, Brown JR, Koff MD, et al. Multiple reservoirs contribute to intraoperative bacterial transmission. Anesth Analg 2012;114(6):1236-1248
13. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271(20):1598-1601
14. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160(3):976-181
15. Renaud B, Brun-Buisson C. Outcomes of primary and catheterrelated bacteremia: a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163(7):1584-1590
16. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheterrelated bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136(2):229-234
17. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 2006;34(8):2084-2089
18. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132(5):391-402
19. Elward AM, Hollenbeak CS, Warren DK, Fraser VJ. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2005;115(4): 868-872
20. Mermel LA. Infections caused by intravascular devices. In: Pfeiffer JA, ed. APIC Text of Infection Control and Epidemiology. 2nd ed. St. Louis: Mosby, 2000:30-38
21. Almuneef MA, Memish ZA, Balkhy HH, Hijazi O, Cunningham G, Francis C. Rate, risk factors and outcomes of catheterrelated bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J Hosp Infect 2006;62(2):207-213
22. Alonso-Echanove J, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003;24(12):916-925
23. Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 2005;9(6):R631-R635
24. Rey C, Alvarez F, De-La-Rua V, et al. Intervention to reduce catheter-related bloodstream infections in a pediatric intensive care unit. Intensive Care Med 2011;37(4):678-685
25. Lorente L, Jimenez A, Naranjo C, et al. Higher incidence of catheter-related bacteremia in jugular site with tracheostomy than in femoral site. Infect Control Hosp Epidemiol 2010;31(3): 311-313
26. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996; 17(3):150-158
27. Cimiotti JP, Haas J, Saiman L, Larson EL. Impact of staffing on bloodstream infections in the neonatal intensive care unit. Arch Pediatr Adolesc Med 2006;160(8):832-836
28. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001;286(6):700-707
29. Raad I, Darouiche R, Dupuis J, et al; Texas Medical Center Catheter Study Group. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997;127(4):267-274
30. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 2004;22(15):3163-3171
31. National Healthcare Safety Network, Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) Manual: Patient Safety Component Protocol. July 2 http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. Accessed September 28, 2013
32. Niedner MF. The harder you look, the more you find: catheterassociated bloodstream infection surveillance variability. Am J Infect Control 2010;38(8):585-595
33. Lin MY, Hota B, Khan YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304(18):2035-2041
34. Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B, Sung L. Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis 2011;53(7):697-710
35. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49(1):1-45
36. O'Grady NP, Alexander M, Dellinger EP, et al; Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002;51(RR-10):1-29
37. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52(9):e162-e193
38. Institute for Healthcare Improvement. http://www.ihi.org. March 11, 2014
39. Saint S. Prevention of intravascular catheter-associated infections. In: Making Health Care Safer. Agency for Healthcare Research and Quality, 2 http://www.ahrq.gov/clinic/ptsafety/, chapter March 11, 2014
40. Huang EY, Chen C, Abdullah F, et al. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2011;46(10):2000-2011
41. The Joint Commission. Preventing Central Line-Associated Bloodstream Infections: A Global Challenge, A Global Perspective. Oakbrook Terrace, IL: The Joint Commission, 2 http:// www.jointcommission.org/assets/1/18/CLABSI_Monograph.pdf. March 11, 2014
42. Association for Professionals in Infection Control and Epidemiology (APIC). Guide to the Elimination of Catheter-Related Bloodstream Infections. Chicago: APIC, 2009
43. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs 2011;S34
44. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355(26):2725-2732
45. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32(10):2014-2020
46. Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2 MMWR Morb Mortal Wkly Rep 2005; 54(40):1013-1016
47. Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control 2011;39(8):640-646
48. Halton KA, Cook D, Paterson DL, Safdar N, Graves N. Costeffectiveness of a central venous catheter care bundle. PLoS ONE 2010;5(9):e12815
49. Helder O, van den Hoogen A, de Boer C, van Goudoever J, Verboon-Maciolek M, Kornelisse R. Effectiveness of non-pharmacological interventions for the prevention of bloodstream infections in infants admitted to a neonatal intensive care unit: a systematic review. Int J Nurs Stud 2013;50(6):819-831
50. Pronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010;340: c309
51. Pronovost PJ, Berenholtz SM, Goeschel CA, et al. Creating high reliability in health care organizations. Health Serv Res 2006; 41(4 pt 2):1599-1617
52. Furuya EY, Dick A, Perencevich EN, Pogorzelska M, Goldmann D, Stone PW. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS ONE 2011;6(1):e15452
53. Guerin K, Wagner J, Rains K, Bessesen M. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control 2010;38(6): 430-433
54. Miller MR, Griswold M, Harris JM 2nd, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010;125(2):206-213
55. Miller MR, Niedner MF, Huskins WC, et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics 2011;128(5):e1077-e1083
56. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians- in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132(8):641-648
57. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355(9218):1864-1868
58. Coopersmith CM, Rebmann TL, Zack JE, et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002;30(1):59-64
59. Warren DK, Zack JE, Cox MJ, Cohen MM, Fraser VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med 2003;31(7):1959-1963
60. Warren DK, Zack JE, Mayfield JL, et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004; 126(5):1612-1618
61. Lobo RD, Levin AS, Oliveira MS, et al. Evaluation of interventions to reduce catheter-associated bloodstream infection: continuous tailored education versus one basic lecture. Am J Infect Control 2010;38(6):440-448
62. Cherry MG, Brown JM, Neal T, Ben Shaw N. What features of educational interventions lead to competence in aseptic insertion and maintenance of CV catheters in acute care? BEME Guide Med Teach 2010;32(3):198-218
63. Joint Commission on Accreditation of Healthcare Organizations. Assessing Hospital Staff Competence. Oakbrook Terrace, IL: Joint Commission Resources, 2007
64. Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Use of simulation-based education to reduce catheter-related bloodstream infections. Arch Intern Med 2009;169(15):1420-1423
65. Khouli H, Jahnes K, Shapiro J, et al. Performance of medical residents in sterile techniques during central vein catheterization: randomized trial of efficacy of simulation-based training. Chest 2011;139(1):80-87
66. Ma IW, Brindle ME, Ronksley PE, Lorenzetti DL, Sauve RS, Ghali WA. Use of simulation-based education to improve outcomes of central venous catheterization: a systematic review and meta-analysis. Acad Med 2011;86(9):1137-1147
67. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167(19):2073-2079
68. O'Horo JC, Silva GL, Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012;33(3):257-267
69. Montecalvo MA, McKenna D, Yarrish R, et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med 2012; 125(5):505-511
70. Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013; 381(9872):1099-1106
71. Munoz-Price LS, Hota B, Stemer A, Weinstein RA. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30(11):1031-1035
72. Medina A, Serratt T, Pelter M, Brancamp T. Decreasing central line-associated bloodstream infections in the non-ICU population. J Nurs Care Qual 2014;29(2):133-140
73. Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010;31(8):846-849
74. Bryant KA, Zerr DM, Huskins WC, Milstone AM. The past, present, and future of healthcare-associated infection prevention in pediatrics: catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2010;31(suppl 1):S27-S31
75. Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012;32(1):4-9
76. Andersen C, Hart J, Vemgal P, Harrison C. Prospective evaluation of a multi-factorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants. J Hosp Infect 2005;61(2):162-167
77. Taylor T, Massaro A, Williams L, et al. Effect of a dedicated percutaneously inserted central catheter team on neonatal catheter- related bloodstream infection. Adv Neonatal Care 2011; 11(2):122-128
78. Garland JS, Alex CP, Uhing MR, Peterside IE, Rentz A, Harris MC. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009;29(12):808-813
79. Curry S, Honeycutt M, Goins G, Gilliam C. Catheter-associated bloodstream infections in the NICU: getting to zero. Neonatal Netw 2009;28(3):151-155
80. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconateimpregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107(6):1431-1436
81. Tsuchida T, Makimoto K, Toki M, Sakai K, Onaka E, Otani Y. The effectiveness of a nurse-initiated intervention to reduce catheter-associated bloodstream infections in an urban acute hospital: an intervention study with before and after comparison. Int J Nurs Stud 2007;44(8):1324-1333
82. Gozu A, Clay C, Younus F. Hospital-wide reduction in central line-associated bloodstream infections: a tale of two small community hospitals. Infect Control Hosp Epidemiol 2011;32(6): 619-622
83. Occupational Health and Safety Administration, US Department of Labor. http://www.osha.gov. March 11, 2014
84. Yilmaz G, Koksal I, Aydin K, Caylan R, Sucu N, Aksoy F. Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. JPEN J Parenter Enteral Nutr 2007; 31(4):284-287
85. Boyce JM, Pittet D; Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002;51(RR-16):1-45
86. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005;33(7):392-397
87. Capretti MG, Sandri F, Tridapalli E, Galletti S, Petracci E, Faldella G. Impact of a standardized hand hygiene program on the incidence of nosocomial infection in very low birth weight infants. Am J Infect Control 2008;36(6):430-435
88. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19(11):842-845
89. Parienti JJ, du Cheyron D, Timsit JF, et al. Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults. Crit Care Med 2012;40(5):1627-1634
90. Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang FL. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev 2012;(3): CD004084
91. Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008;299(20):2413-2422
92. Timsit JF, Bouadma L, Mimoz O, et al. Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients: causal analysis of two randomized trials. Am J Respir Crit Care Med 2013;188(10):1232-1239
93. de Jonge RC, Polderman KH, Gemke RJ. Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med 2005;6(3):329-339
94. Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med 2012;40(8):2479-2485
95. Lorente L, Jimenez A, Roca I, Martin MM, Mora ML. Influence of tracheostomy on the incidence of catheter-related bloodstream infection in the catheterization of jugular vein by posterior access. Eur J Clin Microbiol Infect Dis 2011;30(9):1049-1051
96. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005;128(2):489-495
97. Chopra V, Anand S, Krein SL, Chenoweth C, Saint S. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med 2012; 125(8):733-741
98. Ajenjo MC, Morley JC, Russo AJ, et al. Peripherally inserted central venous catheter-associated bloodstream infections inhospitalized adult patients. Infect Control Hosp Epidemiol 2011; 32(2):125-130
99. Karakitsos D, Labropoulos N, De Groot E, et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 2006;10(6):R162
100. Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003;327(7411):361
101. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91(3B): 197S-205S.
102. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15(4 pt 1):231-238
103. Hu KK, Lipsky BA, Veenstra DL, Saint S. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control 2004; 32(3):142-146
104. Young EM, Commiskey ML, Wilson SJ. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention. Am J Infect Control 2006;34(8):503-506
105. Ishikawa Y, Kiyama T, Haga Y, et al. Maximal sterile barrier precautions do not reduce catheter-related bloodstream infections in general surgery units: a multi-institutional randomized controlled trial. Ann Surg 2010;251(4):620-623
106. Burrell AR, McLaws ML, Murgo M, Calabria E, Pantle AC, Herkes R. Aseptic insertion of central venous lines to reduce bacteraemia. Med J Aust 2011;194(11):583-587
107. Lee DH, Jung KY, Choi YH. Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008;29(10):947-950
108. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338(8763):339-343
109. Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995;14(6):510-516
110. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000;31(4):1001-1007
111. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136(11):792-801
112. Maiwald M, Chan ES. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PLoS ONE 2012; 7(9):e44277
113. Robert J, Fridkin SK, Blumberg HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000;21(1):12-17
114. Stone PW, Mooney-Kane C, Larson EL, et al. Nurse working conditions and patient safety outcomes. Med Care 2007;45(6): 571-578
115. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993;31(3):475-479
116. Luebke MA, Arduino MJ, Duda DL, et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998;26(4):437-441
117. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect 2003;54(4):288-293
118. Munoz-Price LS, Dezfulian C, Wyckoff M, et al. Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Crit Care Med 2012;40(5): 1464-1469
119. Soothill JS, Bravery K, Ho A, Macqueen S, Collins J, Lock P. A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before/after study on a hemopoietic stem cell transplant ward. Am J Infect Control 2009;37(8):626-630
120. Hong H, Morrow DF, Sandora TJ, Priebe GP. Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity. Am J Infect Control 2013;41(8):e77-e79
121. Rupp ME, Yu S, Huerta T, et al. Adequate disinfection of a split-septum needleless intravascular connector with a 5- second alcohol scrub. Infect Control Hosp Epidemiol 2012;33(7): 661-665
122. Simmons S, Bryson C, Porter S. "Scrub the hub": cleaning duration and reduction in bacterial load on central venous catheters. Crit Care Nurs Q 2011;34(1):31-35
123. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med 1992;116(9):737-738
124. Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use: internal medicine house staff participate in a successful quality improvement project. Arch Intern Med 1994;154(16):1829-1832
125. Rotz S, Sopirala MM. Assessment beyond central line bundle: audits for line necessity in infected central lines in a surgical intensive care unit. Am J Infect Control 2012;40(1):88-89
126. Cload B, Day AG, Ilan R. Evaluation of unnecessary central venous catheters in critically ill patients: a prospective observational study. Can J Anaesth 2010;57(9):830-835
127. Seguin P, Laviolle B, Isslame S, Coue A, Malledant Y. Effectiveness of simple daily sensitization of physicians to the duration of central venous and urinary tract catheterization. Intensive Care Med 2010;36(7):1202-1206
128. Faruqi A, Medefindt J, Dutta G, Philip SA, Tompkins D, Carey J. Effect of a multidisciplinary intervention on central line utilization in an acute care hospital. Am J Infect Control 2012; 40(6):e211-e215
129. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings forsite care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994;22(11):1729-1737
130. Rasero L, Degl'Innocenti M, Mocali M. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. Haematologica 2000;85:275-279
131. Timsit JF, Bouadma L, Ruckly S, et al. Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med 2012;40(6):1707-1714
132. Gillies D, O'Riordan L, Wallen M, Morrison A, Rankin K, Nagy S. Optimal timing for intravenous administration set replacement. Cochrane Database Syst Rev 2005;(4):CD003588
133. Ullman AJ, Cooke ML, Gillies D, et al. Optimal timing for intravascular administration set replacement. Cochrane Database Syst Rev 2013;(9):CD003588
134. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991;40(5):934-938
135. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp- Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995; 31(3):189-193
136. Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA. Spontaneous rupture of polyurethane peritoneal catheter: a possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 1998;13(7):1870-1871
137. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003;14(1):169-179
138. Fong IW. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine. Postgrad Med J 1993;69(suppl 3):S15-S17
139. Battistella M, Bhola C, Lok CE. Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report. Am J Kidney Dis 2011;57(3):432-441
140. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008; 148(8):596-605
141. Gastmeier P, Geffers C, Brandt C, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 2006;64(1):16-22
142. Zingg W, Sax H, Inan C, et al. Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected. J Hosp Infect 2009;73(1):41-46
143. National Healthcare Safety Network, Department of Health and Human Services, Centers for Disease Control and Prevention. Surveillance for central line-associated bloodstream infections (CLABSI). http://www.cdc.gov/nhsn/acute-care-hospital/clabsi /index.html. March 11, 2014
144. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2 Am J Infect Control 2007;35(5):290-301
145. Woeltje KF, McMullen KM, Butler AM, Goris AJ, Doherty JA. Electronic surveillance for healthcare-associated central line-associated bloodstream infections outside the intensive care unit. Infect Control Hosp Epidemiol 2011;32(11):1086-1090
146. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127(4):257-266
147. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281(3):261-267
148. Darouiche RO, Raad II, Heard SO, et al; Catheter Study Group. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340(1):1-8
149. Hanna HA, Raad II, Hackett B, et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 2003;124(3):1030-1038
150. McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobialimpregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 2003;37(1):65-72
151. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005;143(8):570-580
152. Wang H, Huang T, Jing J, et al. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J Hosp Infect 2010;76(1):1-11
153. Cherry-Bukowiec JR, Denchev K, Dickinson S, et al. Prevention of catheter-related blood stream infection: back to basics? Surg Infect (Larchmt) 2011;12(1):27-32
154. Guleri A, Kumar A, Morgan RJ, Hartley M, Roberts DH. Anaphylaxis to chlorhexidine-coated central venous catheters: a case series and review of the literature. Surg Infect (Larchmt) 2012;13(3):171-174
155. Levy I, Katz J, Solter E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J 2005;24(8):676-679
156. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 2006;58(2): 281-287
157. Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidineimpregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009;301(12):1231-1241
158. Ruschulte H, Franke M, Gastmeier P, et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009;88(3):267-272
159. Camins BC, Richmond AM, Dyer KL, et al. A crossover intervention trial evaluating the efficacy of a chlorhexidineimpregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infect Control Hosp Epidemiol 2010;31(11):1118-1123
160. Timsit JF, Mimoz O, Mourvillier B, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012;186(12):1272-1278
161. Menyhay SZ, Maki DG. Preventing central venous catheter-associated bloodstream infections: development of an antisep-tic barrier cap for needleless connectors. Am J Infect Control 2008;36(10):S174e1-S174e5
162. Oto J, Imanaka H, Konno M, Nakataki E, Nishimura M. A prospective clinical trial on prevention of catheter contamination using the hub protection cap for needleless injection device. Am J Infect Control 2011;39(4):309-313
163. Sweet MA, Cumpston A, Briggs F, Craig M, Hamadani M. Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control 2012;40(10):931-934
164. Wright MO, Tropp J, Schora DM, et al. Continuous passive disinfection of catheter hubs prevents contamination and bloodstream infection. Am J Infect Control 2013;41(1):33-38
165. Loftus RW, Brindeiro BS, Kispert DP, et al. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system. Anesth Analg 2012;115(6):1315-1323
166. Bertini G, Elia S, Ceciarini F, Dani C. Reduction of catheterrelated bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system. Early Hum Dev 2013;89(1):21-25
167. Chelliah A, Heydon KH, Zaoutis TE, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007;26(9):816-820
168. Bhutta A, Gilliam C, Honeycutt M, et al. Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach. BMJ 2007;334(7589):362-365
169. Weber JM, Sheridan RL, Fagan S, Ryan CM, Pasternack MS, Tompkins RG. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial- coated catheters in a pediatric burn population. J Burn Care Res 2012;33(4):539-543
170. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999;43(9):2200-2204
171. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000;18(6):1269-1278
172. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006;43(4):474-484
173. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter- related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 2008;23(5):1666-1672
174. Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C. Antibiotic- based catheter lock solutions for prevention of catheter- related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 2010;75(1):1-11
175. Oliveira C, Nasr A, Brindle M, Wales PW. Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics 2012;129(2):318-329
176. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47(1):83-93
177. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 2007;31(4):302-305
178. Slobbe L, Doorduijn JK, Lugtenburg PJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS ONE 2010;5(5):e10840
179. Cober MP, Kovacevich DS, Teitelbaum DH. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. JPEN J Parenter Enteral Nutr 2011;35(1):67-73
180. Heng AE, Abdelkader MH, Diaconita M, et al. Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction. Clin Nephrol 2011;75(6):534-541
181. Hemmelgarn BR, Moist LM, Lok CE, et al. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011;364(4):303-312
182. McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985;6(4):419-425
183. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990;15(1):95-102
184. Sandoe JA, Kumar B, Stoddart B, et al. Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients. J Antimicrob Chemother 2003;52(5):877-879
185. van de Wetering MD, van Woensel JB, Kremer LC, Caron HN. Prophylactic antibiotics for preventing early gram-positive central venous catheter infections in oncology patients: a Cochrane systematic review. Cancer Treat Rev 2005;31(3):186-196
186. Karanlik H, Kurul S, Saip P, et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. Am J Surg 2011;202(1):10-15
187. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheterrelated sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit CareMed 1990;18(10): 1073-1079
188. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992;327(15):1062-1068
189. Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997;25(8):1417-1424
190. Maragakis LL, Bradley KL, Song X, et al. Increased catheterrelated bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006;27(1):67-70
191. Field K, McFarlane C, Cheng AC, et al. Incidence of catheterrelated bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infect Control Hosp Epidemiol 2007;28(5):610-613
192. Salgado CD, Chinnes L, Paczesny TH, Cantey JR. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol 2007;28(6):684-688
193. Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis 2007;44(11):1408-1414
194. Jarvis WR, Murphy C, Hall KK, et al. Health care-associated bloodstream infections associated with negative- or positivepressure or displacement mechanical valve needleless connectors. Clin Infect Dis 2009;49(12):1821-1827
195. Miller JM, Goetz AM, Squier C, Muder RR. Reduction in nosocomial intravenous device-related bacteremias after institution of an intravenous therapy team. J Intraven Nurs 1996; 19(2):103-106
196. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998;158(5):473-477
197. Koh DB, Gowardman JR, Rickard CM, Robertson IK, Brown A. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. Crit Care Med 2008;36(2):397-402
198. Lucet JC, Bouadma L, Zahar JR, et al. Infectious risk associated with arterial catheters compared with central venous catheters. Crit Care Med 2010;38(4):1030-1035
199. Tokars JI, Klevens RM, Edwards JR, Horan TC. Measurement of the impact of risk adjustment for central line-days on interpretation of central line-associated bloodstream infection rates. Infect Control Hosp Epidemiol 2007;28(9):1025-1029
200. Klevens RM, Tokars JI, Edwards J, Horan T. Sampling for collection of central line-day denominators in surveillance of healthcare-associated bloodstream infections. Infect Control Hosp Epidemiol 2006;27(4):338-342
201. Thompson ND, Edwards JR, Bamberg W, et al. Evaluating the accuracy of sampling to estimate central line-days: simplification of the National Healthcare Safety Network surveillance methods. Infect Control Hosp Epidemiol 2013;34(3):221-228
202. Casey AL, Karpanen TJ, Nightingale P, Cook M, Elliott TS. Microbiological comparison of a silver-coated and a noncoated needleless intravascular connector in clinical use. J Hosp Infect 2012;80(4):299-303
203. Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev 2011;(11): CD003827
204. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillinresistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50(2):210-217
205. Bizzarro MJ, Sabo B, Noonan M, Bonfiglio MP, Northrup V, Diefenbach K. A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010;31(3):241-248
206. Sawyer M, Weeks K, Goeschel CA, et al. Using evidence, rigorous measurement, and collaboration to eliminate central catheter-associated bloodstream infections. Crit Care Med 2010;38(suppl 8):S292-S298
207. Widmer AF, Nettleman M, Flint K, Wenzel RP. The clinical impact of culturing central venous catheters: a prospective study. Arch Intern Med 1992;152(6):1299-1302
208. Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995;20(3):593-597
209. Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155(11):1177-1184
210. Wong ES, Rupp ME, Mermel L, et al. Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 2005;26(2):210-212
211. Aswani MS, Reagan J, Jin L, Pronovost PJ, Goeschel C. Variation in public reporting of central line-associated bloodstream infections by state. Am J Med Qual 2011;26(5):387-395
212. Talbot TR, Bratzler DW, Carrico RM, et al. Public reporting of health care-associated surveillance data: recommendations from the Healthcare Infection Control Practices Advisory Committee. Ann Intern Med 2013;159(9):631-635
213. Healthcare-Associated Infection Working Group of the Joint Public Policy Committee. Essentials of Public Reporting of Healthcare- Associated Infections: A Tool Kit. 2 http://www.shea-online.org/Assets/files/Essentials_of_Public_Reporting_Tool_Kit.pdf. March 11, 2014
214. National Quality Forum (NQF). National Voluntary Consensus Standards for the Reporting of Healthcare-Associated Infection Data. Washington, DC: NQF, 2 http://www.qualityforum.org/Publications/2008/03/National_Voluntary_Consensus_Standards_for_the_Reporting_of_Healthcare-Associated _Infection_Data.aspx. March 11, 2014
215. Weaver SJ, Lubomksi LH, Wilson RF, Pfoh ER, Martinez KA, Dy SM. Promoting a culture of safety as a patient safety strategy: a systematic review. Ann Intern Med 2013;158(5 pt 2):369-374
216. Hatler CW, Mast D, Corderella J, et al. Using evidence and process improvement strategies to enhance healthcare outcomes for the critically ill: a pilot project. Am J Crit Care 2006; 15(6):549-555
217. On the CUSP: Stop BSI CLABSI Toolkit. http://www.onthecuspstophai.org/on-the-cuspstop-bsi/toolkits-and-resources/.
218. Tools for Reducing Line Associated Blood Stream Infections. http://www.ahrq.gov/professionals/education/curriculum-tools/clabsitools/index.html.
219. Silow-Carrol S, Edwards JN. Eliminating Central Line Infections and Spreading Success at High-Performing Hospitals. New York: Commonwealth Fund, 2011
220. Huang GC, Newman LR, Schwartzstein RM, et al. Procedural competence in internal medicine residents: validity of a central venous catheter insertion assessment instrument. Acad Med 2009;84(8):1127-1134
221. Safdar N, Abad C. Educational interventions for prevention of healthcare-associated infection: a systematic review. Crit Care Med 2008;36(3):933-940
222. Smith JS, Kirksey KM, Becker H, Brown A. Autonomy and self-efficacy as influencing factors in nurses' behavioral intention to disinfect needleless intravenous systems. J Infus Nurs 2011;34(3):193-200
223. Faruqi A, Medefindt J, Dutta G, Philip SA, Tompkins D, Carey J. Effect of a multidisciplinary intervention on central line utilization in an acute care hospital. Am J Infect Control 2012; 40(6):e211-e215
224. Warren D, Zack J, Mayfield J, et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004;126(5): 1612-1618
225. Warren DK, Yokoe DS, Climo MW, et al. Preventing catheterassociated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the Prevention Epicenter Program. Infect Control Hosp Epidemiol 2006;27(1):8-13
226. Chittick P, Sherertz RJ. Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit. Crit Care Med 2010;38(suppl 8):S363-S372
227. Moureau N, Lamperti M, Kelly LJ, et al. Evidence-based consensus on the insertion of central venous access devices: definition of minimal requirements for training. Br J Anaesth 2013; 110(3):347-356
228. Warren DK, Cosgrove SE, Diekema DJ, et al. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2006;27(7):662-669
229. Sannoh S, Clones B, Munoz J, Montecalvo M, Parvez B. A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection. Am J Infect Control 2010;38(6):424-429
230. Banks CM, Gilmartin H, Fink RM. Education methods for maintaining nursing competency in low-volume, high-risk procedures in the rural setting: bridging the theory to practice gap. J Nurses Staff Dev 2010;26(3):E1-E7
231. Comer A, Harris AD, Shardell MP, et al. Web-based training improves knowledge about central line bloodstream infections. Infect Control Hosp Epidemiol 2011;32(12):1219-1222
232. Guembe M, Pérez-Parra A, Gómez E, et al. Impact on knowledge and practice of an intervention to control catheter infection in the ICU. Eur J Clin Microbiol Infect Dis 2012;31(10): 2799-2808
233. Zack J. Zeroing in on zero tolerance for central line-associated bacteremia. Am J Infect Control 2008;36(10):Se1
234. Aboelela SW, Stone PW, Larson EL. Effectiveness of bundled behavioural interventions to control healthcare-associated infections: a systematic review of the literature. J Hosp Infect 2007; 66(2):101-108
235. Sherertz R, Ely E, Westbrook D, et al. Education of physiciansin- training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132(8):641-648
236. Walz JM, Memtsoudis SG, Heard SO. Analytic reviews: prevention of central venous catheter bloodstream infections. J Intensive Care Med 2010;25(3):131-138
237. Rodriguez-Paz JM, Kennedy M, Salas E, et al. Beyond "see one, do one, teach one": toward a different training paradigm. Qual Saf Health Care 2009;18(1):63-68
238. Ahya SN, Barsuk JH, Cohen ER, Tuazon J, McGaghie WC, Wayne DB. Clinical performance and skill retention after simulation- based education for nephrology fellows. Semin Dial 2012;25(4):470-473
239. Ault MJ, Rosen BT, Ault B. The use of tissue models for vascular access training: phase I of the procedural patient safety initiative. J Gen Intern Med 2006;21(5):514-517
240. Evans LV, Dodge KL. Simulation and patient safety: evaluative checklists for central venous catheter insertion. Qual Saf Health Care 2010;19(suppl 3):i42-i46
241. Ahlin C, Klang-Söderkvist B, Brundin S, Hellström B, Pettersson K, Johansson E. Implementation of a written protocol for management of central venous access devices: a theoretical and practical education, including bedside examinations. J Infus Nurs 2006;29(5):253-259
242. Segreti J, Garcia-Houchins S, Gorski L, et al. Consensus conference on prevention of central line-associated bloodstream infections: 2 J Infus Nurs 2011;34(2):126-133
243. Labeau S, Vereecke A, Vandijck DM, Claes B, Blot SI. Critical care nurses' knowledge of evidence-based guidelines for preventing infections associated with central venous catheters: an evaluation questionnaire. Am J Crit Care 2008;17(1):65-71
244. Labeau SO, Vandijck DM, Rello J, et al. Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med 2009;37(1):320-323
245. Marra AR, Cal RG, Durao MS, et al. Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control 2010;38(6):434-439
246. Wheeler DS, Giaccone MJ, Hutchinson N, et al. A hospitalwide quality-improvement collaborative to reduce catheterassociated bloodstream infections. Pediatrics 2011;128(4):e995-e1004
247. Harting BP, Talbot TR, Dellit TH, et al. University Health- System Consortium quality performance benchmarking study of the insertion and care of central venous catheters. Infect Control Hosp Epidemiol 2008;29(5):440-442
248. Jeffries HE, Mason W, Brewer M, et al. Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009;30(7):645-651
249. Stevens TP, Schulman J. Evidence-based approach to preventing central line-associated bloodstream infection in the NICU. Acta Paediatr Suppl 2012;101(464):11-16
250. Powers RJ, Wirtschafter DW. Decreasing central line associated bloodstream infection in neonatal intensive care. Clin Perinatol 2010;37(1):247-272
251. Rupp ME, Cassling K, Faber H, et al. Hospital-wide assessment of compliance with central venous catheter dressing recommendations. Am J Infect Control 2013;41(1):89-91
252. O'Grady N, Alexander M, Burns L, Dellinger E. Guideline for the Prevention of Intravascular Catheter-Related Infections, 2 Atlanta: Centers for Disease Control and Prevention, 2 http://www.cdc.gov/hicpac/BSI/BSI-guidelines-2html. Accessed April 1, 2011
253. Son CH, Daniels TL, Eagan J, et al. Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey. Infect Control Hosp Epidemiol 2012; 33(9):869-874
254. Woeltje KF, McMullen KM, Butler AM, Goris AJ, Doherty JA. Electronic surveillance for healthcare-associated central line-associated bloodstream infections outside the intensive care unit. Infect Control Hosp Epidemiol 2011;32(11):1086-1090
255. Berhe M, Edmond MB, Bearman G. Measurement and feedback of infection control process measures in the intensive care unit: impact on compliance. Am J Infect Control 2006;34(8): 537-539
256. Assanasen S, Edmond M, Bearman G. Impact of 2 different levels of performance feedback on compliance with infection control process measures in 2 intensive care units. Am J Infect Control 2008;36(6):407-413
257. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-926
258. GRADE. Canadian Task Force on Preventive Health Care website. http://canadiantaskforce.ca/methods/grade/. Accessed December 31, 2